Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett’s esophagus*
Authors:
- 1 October 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 16 (3) , 193-198
Abstract
Summary. Barrett’s esophagus is a metaplastic condition associated with gastroesophageal reflux disease and an increased risk for adenocarcinoma. Acid plays aKeywords
This publication has 21 references indexed in Scilit:
- Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trialAlimentary Pharmacology & Therapeutics, 2000
- Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 2000
- Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitorAlimentary Pharmacology & Therapeutics, 2000
- Proton pump inhibitors for Barrett's oesophagusGut, 2000
- Oesophageal motility defects associated with nocturnal gastro‐oesophageal reflux on proton pump inhibitorsAlimentary Pharmacology & Therapeutics, 1999
- Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal AdenocarcinomaNew England Journal of Medicine, 1999
- Gastro‐oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitorsAlimentary Pharmacology & Therapeutics, 1998
- The roles of excessive gastro-oesophageal reflux, disordered oesophageal motility and decreased mucosal sensitivity in the pathogenesis of Barrettʼs oesophagusEuropean Journal of Gastroenterology & Hepatology, 1997
- Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.Journal of Clinical Investigation, 1996
- Epidemiology and Natural History of Gastro-Oesophageal Reflux DiseaseDigestion, 1992